SLXN SCHEDULE 13G: SEC filing
Filed with the SEC on · accession 0001213900-26-091333
SLXN filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 18, 2026. Intracoastal Capital LLC, along with Mitchell P. The stock moved -0.9% by the first close after the filing.
Summary of the filing
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed a Schedule 13G joint filing agreement regarding their passive ownership position in Silexion Therapeutics Corp.
Key details
How SLXN stock reacted
Close before
$0.42
Aug 17, 2026
First close after
-0.90%
$0.42
5 trading days
-12.89%
$0.37
Since filing
-64.74%
$0.15
✦ Ask GOAX AI about this filing — what it means for SLXN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SLXN?
Click hereFrequently asked questions
What did SLXN file with the SEC on Aug 18, 2026?
SLXN filed a SCHEDULE 13G (SEC filing). Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed a Schedule 13G joint filing agreement regarding their passive ownership position in Silexion Therapeutics Corp.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did SLXN stock react to this filing?
SLXN closed at $0.42 before the filing and $0.42 on Aug 18, 2026 (-0.90%). Five trading days later: $0.37 (-12.89%).
Other SLXN SEC filings
- S-3 · Shelf registrationOct 28, 2026
- 8-K · SEC filingOct 26, 2026
- DEF 14A · Stock splitOct 5, 2026
- 8-K · Fda approvalSep 30, 2026
- 424B3 · Secondary offeringSep 29, 2026
- 8-K · SEC filingSep 29, 2026
- 8-K · Fda approvalSep 28, 2026
- SCHEDULE 13D/A · Activist campaignSep 28, 2026
- 8-K · SEC filingSep 25, 2026
- 8-K · SEC filingSep 25, 2026
Get alerts when SLXN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days